Neumora Therapeutics Inc (NMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 42,190 | 52,864 | 58,480 | 57,700 | 54,040 |
| Operating Income | -42,190 | -52,864 | -58,480 | -57,700 | -54,040 |
| Interest Expense | 1,820 | 1,854 | 2,036 | 747 | 436 |
| Other Income | 928 | 1,290 | 1,066 | 1,692 | 1,770 |
| Pre-tax Income | -43,082 | -53,428 | -59,450 | -56,755 | -52,706 |
| Income Tax | N/A | 30 | N/A | N/A | 25 |
| Net Income Continuous | -43,082 | -53,458 | -59,450 | -56,755 | -52,731 |
| Net Income | $-43,082 | $-53,458 | $-59,450 | $-56,755 | $-52,731 |
| EPS Basic Total Ops | -0.23 | -0.30 | -0.35 | -0.35 | -0.33 |
| EPS Basic Continuous Ops | -0.23 | -0.30 | -0.35 | -0.35 | -0.33 |
| EPS Diluted Total Ops | -0.23 | -0.30 | -0.35 | -0.35 | -0.33 |
| EPS Diluted Continuous Ops | -0.23 | -0.30 | -0.35 | -0.35 | -0.33 |
| EPS Diluted Before Non-Recurring Items | -0.23 | -0.30 | -0.35 | -0.35 | -0.33 |
| EBITDA(a) | $-41,789 | $-52,438 | $-57,399 | $-58,592 | $-54,614 |